CNSA News : 2019

New CTSI Collaborative Resource Supports Researchers Working With Aging Populations

Through a collaboration with the Miami CTSI, the Center for Cognitive Neuroscience and Aging (CNSA) is now a valuable resource available to the greater research community. The University of Miami CNSA focuses on understanding the aging brain and brain disorders through research, clinical care and education.

Read more »

When to get a memory evaluation

For many of us, it is not until we reach middle age that we start to pay closer attention to our bodies and the way it is aging. We undergo a number of medical screenings and evaluations for conditions such as high blood pressure, diabetes, elevated lipids, cholesterol, and other cardiovascular risk factors.

Read more »

New UM program focuses on building skills for Alzheimer’s caregivers, and supporting them

The University of Miami Health System has developed the Care Partners Program, a 12-month study funded by National Institute on Aging at the National Institutes of Health. The program helps caregivers learn skills that help improve patience and provide cognitive stimuli for patients.

Read more »

Researchers Racing to Find Causes — and Cures — for Alzheimer’s Disease

Like thunderclouds billowing in the skies on a South Florida summer afternoon, the latest statistics for Alzheimer’s disease are a portent of stormy times ahead:

Alzheimer’s disease is now the sixth leading cause of death in the U.S., killing more people than breast cancer and prostate cancer combined.
Every 65 seconds, a new case of Alzheimer’s is diagnosed.
The number of Americans now living with Alzheimer’s has reached nearly six million and is projected to more than double to 14 million by 2050.
Deaths from Alzheimer’s have increased 123 percent over the past 15 years.

Read more »

Center for Cognitive Neuroscience and Aging (CNSA)

CNSA Director Dr. Loewenstein and his colleagues have been awarded a $3.2 million NIH grant as well as a Florida Department of Health Grant to study new and advanced cognitive stress tests as they relate to early biomarkers of Alzheimer’s disease (AD) such as amyloid tau deposition within the brain.

Read more »